Parents fight as company discontinues drug for 'childhood Alzheimer's'

  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 55%

Business News News

Business Business Latest News,Business Business Headlines

Parents say they believe this drug is helping their children; the drug company says research doesn't show a benefit.

in the hopes that another company will take over making the medication that she believes has transformed Marian’s life.Jenna Weets’ son Jeg was diagnosed in 2017. After learning about adrabetadex, she felt hopeful.

Serrano Russi treats Marian and says that the future for children with NPC will be murky after adrabetadex is no longer available.Marian McGlockin, 5, is a "dynamo" who tells knock-knock jokes and plays babysitter with her dolls. When she was first diagnosed with Niemann Pick Type C, she was already losing her ability to speak.remains frustrating. Researchers face challenges because there are fewer people to study, and the condition may progress very differently in different people.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 389. in BUSİNESS

Business Business Latest News, Business Business Headlines